A detailed history of Tudor Financial Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Tudor Financial Inc. holds 1,086 shares of LLY stock, worth $877,672. This represents 0.49% of its overall portfolio holdings.

Number of Shares
1,086
Previous 452 140.27%
Holding current value
$877,672
Previous $400 Million 109.62%
% of portfolio
0.49%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$727.2 - $932.06 $461,044 - $590,926
634 Added 140.27%
1,086 $839 Million
Q3 2024

Nov 21, 2024

BUY
$772.14 - $960.02 $349,007 - $433,929
452 New
452 $400 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $768B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tudor Financial Inc. Portfolio

Follow Tudor Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tudor Financial Inc. with notifications on news.